• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHB2302813 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs(4) Supplementary Application 2023-12-30 Shanghai DESANO Biopharmaceutical Co Ltd view
JYHS2300031 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs(5.2) Import Drug Application 2023-02-22 view
JYHS2300030 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs(5.2) Import Drug Application 2023-02-22 view
JTH2200240 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Disposable Import Drug Application 2022-12-21 view
JYHZ2200202 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs License Renew 2022-07-18 view
CYHS2200758 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs(4) Generic Drug 2022-05-25 Anhui Biochem Bio-Pharmaceutical Co Ltd view
CYHS2200484 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs(4) Generic Drug 2022-03-24 Shanghai DESANO Biopharmaceutical Co Ltd view
JYHZ2100595 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs License Renew 2021-08-05 view
JYHB2001606 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2020-08-28 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2020-11-24 view
JYHB2001605 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2020-08-28 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2020-11-24 view
JYHB2000638 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2020-05-27 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Filed 2020-06-09 view
JYHB2000637 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2020-05-27 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Filed 2020-06-09 view
JYHB1901349 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2019-11-13 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2020-01-20 view
JYHB1901350 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2019-11-13 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2020-01-20 view
JYHB1900177 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2019-02-12 AbbVie Deutschland GmbH & Co. KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2019-09-23 view
JYHB1900178 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2019-02-12 AbbVie Deutschland GmbH & Co. KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2019-09-23 view
JYHB1701091 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2017-08-21 AbbVie Ltd. Abbvie Ltd In Review 2017-08-19 view
JYHZ1700275 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs License Renew 2017-08-21 AbbVie Ltd. Abbvie Ltd Certificate Issued 2018-03-19 view
JYHB1700866 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2017-06-19 AbbVie Ltd. Abbvie Ltd Filed 2017-09-12 view
JYHB1700865 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2017-06-19 AbbVie Ltd. Abbvie Ltd Filed 2017-07-17 view